Clinical factors influencing the absorption of 125I-NPH insulin in diabetic patients

Horm Metab Res. 1983 Jun;15(6):274-8. doi: 10.1055/s-2007-1018694.

Abstract

Clinical factors which might influence the absorption of subcutaneously injected 125I-NPH insulin were studied in 101 diabetics. The disappearance curve was monoexponential after a delay period of 1.5 +/- 0.8 h (mean +/- SD). Lipohypertrophy significantly prolonged insulin absorption (half life (T1/2) = 11.2 +/- 3.1 h, p = 0.0001). Low bicarbonate levels increased the absorption (T1/2 3.9 +/- 2.3 h, p less than 0.05). Lean diabetics had a faster absorption (6.2 +/- 1.9 h) than normal weight diabetics (7.5 +/- 2.0 h, p less than 0.02). Sex, age, diabetes duration and injection depth did not influence T1/2. The half life was significantly inversely correlated to the resting subcutaneous blood flow (r = 0.882, p less than 0.01). The overall interindividual coefficient of variation for insulin absorption in nonketotic diabetics was 27.4%. Also considerable intra-patient day-to-day variation was found (24.5%), and between different injection sites (30.2%). These variations emphasize the drawbacks of conventional insulin therapy in the management of insulin-requiring diabetics.

MeSH terms

  • Absorption
  • Adult
  • Age Factors
  • Body Weight
  • Diabetes Mellitus / metabolism*
  • Diabetic Ketoacidosis / metabolism
  • Female
  • Half-Life
  • Humans
  • Injections, Subcutaneous
  • Insulin, Isophane / metabolism*
  • Iodine Radioisotopes / metabolism*
  • Male
  • Sex Factors

Substances

  • Iodine Radioisotopes
  • Insulin, Isophane